Galderma

@galderma

The world's largest independent global dermatology company

Lausanne
Vrijeme pridruživanja: siječanj 2013.

Tweetovi

Blokirali ste korisnika/cu @galderma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @galderma

  1. 1. velj

    Galderma is Empowering Individuality in the new global campaign launched at IMCAS congress in Paris this week. Meet the different faces for our entire product portfolio. To learn more about the campaign and Galderma´s aesthetic products visit

    Poništi
  2. 31. sij

    Where is the Aesthetic industry going? Galderma VP Alexandre Brennan at IMCAS' World Economic Tribune panel discussion today, January 31, 15:30-18:30

    Poništi
  3. 30. sij

    Join GALDERMA and our GAIN Faculty for an afternoon symposium “Empowering Personalization through the Decades”, Jan 30, at 14:00, Amphi Bleu, Level 2

    Poništi
  4. 30. sij

    Three days in beautiful Paris! Galderma is Empowering Individuality at IMCAS congress in Paris this week.

    Poništi
  5. 29. sij

    Galderma is Empowering Individuality at IMCAS congress in Paris this week starting tomorrow. Visit us at booth n°P254 on level 2

    Poništi
  6. 8. sij

    Wishing you and yours all the very best for 2020 as we commence this new decade as the world’s largest independent dermatology company. Follow us to keep up to date with our Galderma journey.

    Poništi
  7. 20. pro 2019.

    We received a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years

    Poništi
  8. 8. pro 2019.

    Investigational therapy Nemolizumab granted FDA Breakthrough Therapy Designation for the treatment of patients suffering from prurigo nodularis

    Poništi
  9. 29. stu 2019.

    Good nutrition is essential for healthy skin.

    Poništi
  10. 28. stu 2019.

    $180,000 was raised by Galderma’s 5th Annual Wonder Run, benefiting Children’s Skin Disease Foundation and Camp Wonder, now entering its 20th year! Check out a video from the event held in Fort Worth, TX.

    Poništi
  11. 27. stu 2019.

    Good nutrition is essential for healthy skin.

    Poništi
  12. 22. stu 2019.

    Psoriasis is a chronic inflammatory skin disease, usually genetically predisposed.

    Poništi
  13. 12. stu 2019.

    Over the past years, the incidence of non-melanoma and melanoma skin cancers has continued to increase across the globe. The prevention and treatment of skin cancer is one of our key focus areas.

    Poništi
  14. 21. lis 2019.

    Face Up To Rosacea: Galderma launches new campaign to empower and equip rosacea patients to discuss the true burden of their disease with a dermatologist

    Poništi
  15. 13. lis 2019.

    Thank you for visiting our booth and for attending our symposium dedicated to a devastating disease, prurigo nodularis during the

    Poništi
  16. 11. lis 2019.

    Thank you to everyone who attended our Meet The Expert session. Visit us in Hall 8 if you would like to find out more about Galderma’s commitment to skin health

    Poništi
  17. 11. lis 2019.

    Prof. Dr. Martin Schaller highlights how the latest ROSacea Consensus (ROSCO) expert recommend treatment algorithm has simplified the task of effective & treatment by addressing the multiple features of rosacea and aiming for ‘clear’ (IGA 0) skin

    Poništi
  18. 11. lis 2019.

    Prof. Dr. Martin Schaller discusses how tailoring treatment plans based on individual features present can allow dermatologists to help their patients aim for ‘clear’ (IGA 0) skin

    Poništi
  19. 11. lis 2019.

    Prof. Dr. Martin Schaller highlights how the phenotype approach can help reach the correct diagnosis for patients & make aiming for ‘clear’ (IGA 0) skin a possibility, reducing disease burden and improving quality of life

    Poništi
  20. 11. lis 2019.

    We are excited to host a 2nd Meet The Expert session at today. Prof. Dr. Martin Schaller will discuss optimizing treatment outcomes for patients & aiming for ‘clear’ (IGA 0) skin, building on latest ROSacea Consensus (ROSCO) panel recommendations

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·